Evaluation of cytology and visual triage of human papillomavirus-positive women in cervical cancer prevention in India

International Journal of Cancer

Volumn 134, Issue 12, 2014, Pages 2902-2909

  Muwonge, Richard ^a   Wesley, Ramani S ^b   Nene, Bhagwan M ^c   Shastri, Surendra S ^d   Jayant, Kasturi ^c   Malvi, Sylla G ^c   Thara, Somanathan ^b   Sankaranarayanan, Rengaswamy ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b REGIONAL CANCER CENTRE   (India)

^c Nargis Dutt Memorial Cancer Hospital   (India)

^d TATA MEMORIAL HOSPITAL   (India)

Author keywords

cervical intraepithelial neoplasia; cytology; HPV testing; triage; visual inspection with acetic acid

Indexed keywords

ACETIC ACID;

ADULT; ARTICLE; CANCER GRADING; CANCER PREVENTION; CLINICAL EVALUATION; COLPOSCOPY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOLOGY; EMERGENCY HEALTH SERVICE; FEMALE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MIDDLE AGED; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU;

CERVICAL INTRAEPITHELIAL NEOPLASIA; CYTOLOGY; HPV TESTING; TRIAGE; VISUAL INSPECTION WITH ACETIC ACID;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; CROSS-SECTIONAL STUDIES; CYTODIAGNOSIS; CYTOLOGICAL TECHNIQUES; DNA, VIRAL; EARLY DETECTION OF CANCER; FALSE NEGATIVE REACTIONS; FEMALE; HUMAN PAPILLOMAVIRUS DNA TESTS; HUMANS; INDIA; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; TRIAGE; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84897973102     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28627     Document Type: Article

References (38)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM,. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-917.
2. Arbyn M, Castellsague X, de SS, Bruni, L, Saraiya, M, Bray, F, Ferlay, J,. Worldwide burden of cervical cancer in 2008. Ann Oncol 2011; 22: 2675-86.
3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin D M., GLOBOCAN 2008: Cancer incidence and mortality worldwide: IARC cancer base no. 10 [Internet]. Lyon, France: International Agency for Research on Cancer (IARC), 2010.
4. Sankaranarayanan R, Gaffikin L, Jacob M, Sellors J, Robles S,. A critical assessment of screening methods for cervical neoplasia. Int J Gynaecol Obstet 2005; 89 Suppl 2: S4-S12.
5. Sankaranarayanan R, Budukh AM, Rajkumar R,. Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ 2001; 79: 954-62.
6. International Agency for Research on Cancer (IARC). IARC handbooks on cancer prevention. Cervix cancer screening, vol. 10. Lyon, France: IARC Press, 2004.
7. Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE,. Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst 2011.
8. Sankaranarayanan R, Nene BM, Shastri SS, et al. HPV screening for cervical cancer in rural India. N Engl J Med 2009; 360: 1385-94.
9. Sankaranarayanan R, Chatterji R, Shastri SS, et al. Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: results from a multicenter study in India. Int J Cancer 2004; 112: 341-47.
10. Sankaranarayanan R, Wesley R, eds. A practical manual on visual screening for cervical neoplasia, Lyon, France: IARC Press, 2003.
11. Sellors JW, Sankaranarayanan R, eds. Colposcopy and treatment on cervical intraepithelial neoplasia: a beginners' manual, Lyon: IARC Press, 2003. 1-132.
12. StataCorp LP, ed. Stata base reference manual: release 9, College Station, Texas: StataCorp LP, 2005.
13. Kotaniemi-Talonen L, Nieminen P, Anttila A, Hakama M,. Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting. Br J Cancer 2005; 93: 862-67.
14. Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S, Szarewski A, Birembaut P, Kulasingam S, Sasieni P, Iftner T,. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 2006; 119: 1095-101.
15. Arbyn M, Sasieni P, Meijer CJ, Clavel C, Koliopoulos G, Dillner J,. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses. Vaccine 2006; 24 Suppl 3: S3/78-S3/89.
16. Lazcano-Ponce E, Lorincz AT, Cruz-Valdez A, Salmeron J, Uribe P, Velasco-Mondragon E, Nevarez PH, Acosta RD, Hernandez-Avila M,. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial. Lancet 2011; 378: 1868-73.
17. Almonte M, Ferreccio C, Winkler JL, Cuzick J, Tsu V, Robles S, Takahashi R, Sasieni P,. Cervical screening by visual inspection, HPV testing, liquid-based and conventional cytology in Amazonian Peru. Int J Cancer 2007; 121: 796-802.
18. Ferreccio C, Barriga MI, Lagos M, et al. Screening trial of human papillomavirus for early detection of cervical cancer in Santiago, Chile. Int J Cancer 2013; 132: 916-23.
19. Naucler P, Ryd W, Tornberg S, et al. Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening. J Natl Cancer Inst 2009; 101: 88-99.
20. Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, Ratnam S, Coutlee F, Franco EL,. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 2007; 357: 1579-88.
21. Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, Koliopoulos G, Naucler P, Sankaranarayanan R, Peto J,. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine 2012; 30 Suppl 5: F88-F99.
22. Denny L, Kuhn L, Hu CC, Tsai WY, Wright TC, Jr,. Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial. J Natl Cancer Inst 2010; 102: 1557-67.
23. Naucler P, Ryd W, Tornberg S, Strand A, Wadell G, Elfgren K, Radberg T, Strander B, Forslund O, Hansson BG, Rylander E, Dillner J,. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med 2007; 357: 1589-97.
24. Bulkmans NW, Berkhof J, Rozendaal L, et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 2007; 370: 1764-72.
25. Kitchener HC, Almonte M, Thomson C, et al. HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. Lancet Oncol 2009; 10: 672-82.
26. Ronco G, Giorgi-Rossi P, Carozzi F, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 2010; 11: 249-57.
27. Ronco G, Segnan N, Giorgi-Rossi P, et al. Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial. J Natl Cancer Inst 2006; 98: 765-74.
28. Salmeron J, Lazcano-Ponce E, Lorincz A, et al. Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico. Cancer Causes Control 2003; 14: 505-12.
29. Kotaniemi-Talonen L, Anttila A, Malila N, Tarkkanen J, Laurila P, Hakama M, Nieminen P,. Screening with a primary human papillomavirus test does not increase detection of cervical cancer and intraepithelial neoplasia 3. Eur J Cancer 2008; 44: 565-71.
30. Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, Paraskevaidis E,. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 2006; 367: 489-98.
31. Jakobsson M, Gissler M, Sainio S, Paavonen J, Tapper AM,. Preterm delivery after surgical treatment for cervical intraepithelial neoplasia. Obstet Gynecol 2007; 109: 309-13.
32. McCaffery K, Forrest S, Waller J, Desai M, Szarewski A, Wardle J,. Attitudes towards HPV testing: a qualitative study of beliefs among Indian, Pakistani, African-Caribbean and white British women in the UK. Br J Cancer 2003; 88: 42-46.
33. Anhang R, Wright TC, Jr,., Smock L, Goldie SJ., Women's desired information about human papillomavirus. Cancer 2004; 100: 315-20.
34. Arbyn M, Kyrgiou M, Simoens C, Raifu AO, Koliopoulos G, Martin-Hirsch P, Prendiville W, Paraskevaidis E,. Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ 2008; 337: a1284.
35. Mayrand MH, Franco EL,. Integrating novel primary- and secondary-prevention strategies: the next challenge for cervical cancer control. Future Oncol 2010; 6: 1725-33.
36. Kyndi M, Frederiksen K, Kruger KS,. Cervical cancer incidence in Denmark over six decades (1943-2002). Acta Obstet Gynecol Scand 2006; 85: 106-11.
37. Castle PE, Sideri M, Jeronimo J, Solomon D, Schiffman M,. Risk assessment to guide the prevention of cervical cancer. J Low Genit Tract Dis 2008; 12: 1-7.
38. Katki HA, Wacholder S, Solomon D, Castle PE, Schiffman M,. Risk estimation for the next generation of prevention programmes for cervical cancer. Lancet Oncol 2009; 10: 1022-23.